Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Affiliate Revenue > CAN-SPAN Act and Affiliate Responsibility

Tags

  • companies
  • combinations
  • tackle
  • combination products
  • commercial email

  • Links

  • How to Meet Single Flight Attendants
  • Positive Attitude - Can It Make or Break Your Success
  • The Strategic Plan
  • Just Other Articles - CAN-SPAN Act and Affiliate Responsibility

    If there’s one affiliate absolute it is to NEVER, for any reason, send an unsolicited email
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    to anyone that is promoting anything. No commercial messages, unless the recipient has sp
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    cifically requested that you send him/her email promoting a product or service. And don’t
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ever buy, borrow, lease or trade email lists. If you send commercial email at all, careful
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    y read up on spam regulations and penalties at http://www.spamlaws.com/federal/can-spam.sht
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    l.

    The CAN-SPAM (Controlling the Assault of Non-Solicited Pornography and Marketing) Act t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ook effect on January 1, 2004. It is a federal act, enforced by the Federal Trade Commiss
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    on that requires unsolicited commercial email to be labeled as such. Included in the regul
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ations (again, read it all, and any amendments that may be passed) is the requirement that
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ll unsolicited email must include subject lines that are not deceptive, as well as opt-out
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    nstructions and the sender’s physical address. At present, the FTC is authorized to establ
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ish a “do not e-mail” registry similar to the “do not mail” and “do not call” registries, b
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    t it has not yet done so.

    Not wanting to antagonize recipients, however targeted they may
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    be, most mailers stick strictly to the double opt-in method, in which site visitors subscri
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    e to a newsletter or ezine, are sent a confirmation email to the subscriber. Only when the
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    subscriber confirms by return email that they wish to be a subscriber does the site begin s
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ending them emails. Every ezine, newsletter, newsletter link or other email-based commerci
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    l message must include an opt out method, usually a link, as well as the actual street addr
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ess of the mailer.

    There’s just no point in sending unsolicited email. It dilutes your ef
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    orts and damages your reputation and makes you much less attractive as an affiliate partner


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/54601/justotherarticles-CANSPAN-Act-and-Affiliate-Responsibility.html">CAN-SPAN Act and Affiliate Responsibility</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/54601/justotherarticles-CANSPAN-Act-and-Affiliate-Responsibility.html]CAN-SPAN Act and Affiliate Responsibility[/url]

    Related Articles:

    Poster Printing

    Hiring A New Assistant?

    Google Answers Not Answering Any More

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com